Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Comparative Efficacy and safety of new targeted therapies and immunotherapies for metastatic triple negative breast cancer: a network meta-analysis.
Expert Opin Drug Saf. 2023 Mar;22(3):243-252. doi: 10.1080/14740338.2022.2116001. Epub 2022 Sep 4.
Expert Opin Drug Saf. 2023.
PMID: 35998294
Cost-effectiveness of trastuzumab biosimilar combination therapy and drug wastage as first-line treatment for HER2-positive metastatic breast cancer.
Leung JH, Tai YS, Wang SY, Yip Fion HT, Tsung-Chin H, Chan AL.
Leung JH, et al. Among authors: tsung chin h.
Breast. 2022 Oct;65:91-97. doi: 10.1016/j.breast.2022.07.007. Epub 2022 Jul 16.
Breast. 2022.
PMID: 35870421
Free PMC article.
Item in Clipboard
Cite
Cite